We are proud to share that Dr. Art Hsing-Mao Chu, CEO of T-E Meds, was invited to present at the BIO Asia–Taiwan 2024 conference on July 24-28,2024. Dr. Chu’s presentation, titled “Drug Bundle-Based ADC Platform: Achieving Site-Specific Conjugation, DAR of 8 or 12, and Dual Payloads,” highlighted our innovative technology. The talk emphasized how our … Continue reading Join our presentation at the BIO Asia-Taiwan 2024 Conference